Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics DXCM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

DexCom Inc

DXCM
Current price
84.10 USD +0.01 USD (+0.01%)
Last closed 84.78 USD
ISIN US2521311074
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 33 509 464 064 USD
Yield for 12 month -24.03 %
1Y
3Y
5Y
10Y
15Y
DXCM
21.11.2021 - 28.11.2021

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

98.59 USD

P/E Ratio

64.26

Dividend Yield

Financials DXCM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+4 033 000 000 USD

Last Year

+3 622 300 000 USD

Current Quarter

+1 036 000 000 USD

Last Quarter

+1 113 500 000 USD

Current Year

+2 465 700 000 USD

Last Year

+2 288 900 000 USD

Current Quarter

+589 000 000 USD

Last Quarter

+654 000 000 USD
EBITDA 857 800 000 USD
Operating Margin TTM 12.91 %
Price to Earnings 64.26
Return On Assets TTM 5.98 %
PEG Ratio 1.31
Return On Equity TTM 23.72 %
Wall Street Target Price 98.59 USD
Revenue TTM 4 148 000 000 USD
Book Value 5.78 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.50 %
Dividend Yield
Gross Profit TTM 2 465 299 968 USD
Earnings per share 1.33 USD
Diluted Eps TTM 1.33 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -25.80 %
Profit Margin 12.90 %

Stock Valuation DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 64.26
Forward PE 42.37
Enterprise Value Revenue 7.99
Price Sales TTM 8.08
Enterprise Value EBITDA 34.01
Price Book MRQ 14.68

Technical Indicators DXCM

For 52 Weeks

57.52 USD 117.19 USD
50 Day MA 83.32 USD
Shares Short Prior Month 9 375 485
200 Day MA 77.73 USD
Short Ratio 3.29
Shares Short 10 514 753
Short Percent 3.06 %